RKT
Wall Street can’t quite agree, but it likes the vibe
Rocket Companies is getting the classic analyst-treatment: a little applause, a little side-eye, and a whole lot of price targets. In the latest round, Barclays upgraded RKT to Overweight from Equalweight and trimmed its target to $19 from $22 — which is basically Wall Street saying, “We still like it, just maybe not that much.”
The rest of the chorus joins in
BofA Securities also reiterated a Buy rating with a $19 target, while Keefe, Bruyette & Woods went one step sunnier, upgrading Rocket to Outperform from Market Perform and lifting its target to $22 from $20. On the flip side, Citizens came in with a Market Perform initiation, because apparently no stock gets to leave the room without one person crossing their arms.
Why you should care
Rocket lives and dies by housing activity, mortgage demand, and the broader rate backdrop. So when analysts start nudging ratings higher, they’re basically betting that the company’s integration story and eventual housing rebound could have legs — even if the recovery is more tortoise than rocket ship.
Big picture
This isn’t a make-or-break catalyst by itself, but it does show that the bearish crowd isn’t running the table. For investors, the message is simple: Wall Street thinks Rocket still has optionality — it just can’t agree on how shiny the prize really is.